| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048336476 |
| P356 | DOI | 10.1007/S11926-016-0568-X |
| P8608 | Fatcat ID | release_jrtfga53mbdgtngaxsdbbwcdui |
| P698 | PubMed publication ID | 26923254 |
| P50 | author | Cécile Yelnik | Q56563718 |
| P2093 | author name string | Simone Appenzeller | |
| Elizabeth Kozora | |||
| P2860 | cites work | Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome | Q81047205 |
| Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus | Q81484675 | ||
| Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases | Q81811368 | ||
| Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome | Q84229879 | ||
| Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies | Q84557278 | ||
| Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information? | Q84942915 | ||
| Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea | Q85339890 | ||
| Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus | Q28261335 | ||
| Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited | Q28265182 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Anti-beta 2-glycoprotein I antibodies bind to central nervous system | Q28575717 | ||
| Parkinsonism in a patient with antiphospholipid syndrome--case report and literature review | Q31136027 | ||
| Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study | Q33303065 | ||
| Hyperactivity in a mouse model of the antiphospholipid syndrome | Q33338363 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Features associated with epilepsy in the antiphospholipid syndrome | Q33361525 | ||
| Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? | Q33367182 | ||
| The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome | Q33369426 | ||
| Multiple sclerosis associated with antiphospholipid syndrome: diagnostic and therapeutic difficulties | Q33395750 | ||
| Chorea in primary antiphospholipid syndrome is associated with rheumatic fever | Q33396957 | ||
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients | Q33412915 | ||
| The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features | Q33420116 | ||
| Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model | Q33499900 | ||
| High association of anticardiolipin antibodies with psychosis | Q33501832 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature | Q33835528 | ||
| Lymphocytes, autoantibodies and psychosis--coincidence versus etiological factor: an update | Q33945263 | ||
| Population-level evidence for an autoimmune etiology of epilepsy | Q34040405 | ||
| Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage | Q34213820 | ||
| Obsessive-compulsive behavior as presenting symptom of primary antiphospholipid syndrome | Q34637471 | ||
| Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis | Q34687562 | ||
| Transverse myelitis in patients with antiphospholipid antibodies--the importance of early diagnosis and treatment | Q34732827 | ||
| Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome | Q35075610 | ||
| Chorea associated with high titers of antiphospholipid antibodies in the absence of antiphospholipid antibody syndrome | Q35108608 | ||
| Antiphospholipid antibodies and cerebellar ataxia: a clinical analysis and literature review | Q35142791 | ||
| Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. | Q35467118 | ||
| Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome | Q35554870 | ||
| Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke | Q35867162 | ||
| Migraineurs show a high prevalence of antiphospholipid antibodies | Q57272263 | ||
| Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis | Q57602063 | ||
| Migraine and Antiphospholipid Antibodies: No Association Found in Migraine-Discordant Monozygotic Twins | Q58210773 | ||
| Prevalence and Clinical Significance of Anti-phospholipid Antibodies in Multiple Sclerosis: a Study of 89 Patients | Q58854442 | ||
| Dementia and Antiphospholipid Antibodies | Q59416893 | ||
| Anticardiolipin antibodies in migraine | Q70162170 | ||
| Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis | Q71315054 | ||
| Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons | Q72350707 | ||
| Lack of association between antiphospholipid antibodies and migraine | Q72808545 | ||
| Neuropathological changes within the brain of rabbits with experimental model of antiphospholipid syndrome in different time after immunization | Q73517687 | ||
| The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus | Q73594631 | ||
| Migraine and stroke in young women | Q73822136 | ||
| Sticky blood and headache | Q74127765 | ||
| Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study | Q74485208 | ||
| Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study | Q74575122 | ||
| Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? | Q77228517 | ||
| A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus | Q77352546 | ||
| Antiphospholipid syndrome mimicking multiple sclerosis in two patients | Q79349579 | ||
| Lupoid sclerosis: what is the role of antiphospholipid antibodies? | Q80111676 | ||
| A comparative audit of anticardiolipin antibodies in oligoclonal band negative and positive multiple sclerosis | Q80929383 | ||
| No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up | Q36226618 | ||
| Simultaneous deep vein thrombosis and transverse myelitis with negative serology as a first sign of antiphospholipid syndrome: a case report and review of the literature | Q36290624 | ||
| Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). | Q36473943 | ||
| Antiphospholipid antibodies bind ATP: a putative mechanism for the pathogenesis of neuronal dysfunction | Q36509968 | ||
| A patient with bipolar disorder and antiphospholipid syndrome | Q36959771 | ||
| Mania: psychiatric manifestations of the antiphospholipid syndrome | Q37270276 | ||
| Neurological manifestations in patients with antiphospholipid syndrome | Q37311800 | ||
| A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients | Q37702168 | ||
| Pathological gambling and primary antiphospholipid (Hughes) syndrome: a unique neuropsychiatric association | Q37874026 | ||
| Cognitive dysfunction and antiphospholipid antibodies | Q37963790 | ||
| The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus erythematosus | Q39037198 | ||
| Early neuropsychiatric involvement in antiphospholipid syndrome | Q40291856 | ||
| Autoimmunity in depression: increased antiphospholipid autoantibodies | Q40893344 | ||
| Antiphospholipid antibody syndrome presenting with hemichorea | Q42125674 | ||
| Chorea associated with anti-phospholipid antibodies: case report | Q42786711 | ||
| New onset neuromyelitis optica in a young Nigerian woman with possible antiphospholipid syndrome: a case report | Q43229815 | ||
| Antiphospholipid Antibodies in Migraine | Q43514382 | ||
| Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients. | Q43786418 | ||
| Occurrence of factor V Leiden mutation (Arg506Gln) and anticardiolipin antibodies in migraine patients. | Q43971690 | ||
| The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures. | Q44469864 | ||
| The pathogenesis of neural injury in animal models of the antiphospholipid syndrome | Q45122099 | ||
| Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients | Q46112223 | ||
| Primary antiphospholipid syndrome manifesting as partial status epilepticus | Q46251932 | ||
| Antiphospholipid antibody-associated chorea | Q46313657 | ||
| Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome | Q46319206 | ||
| Dramatic response of severe headaches to anticoagulation in a patient with antiphospholipid syndrome | Q46350372 | ||
| Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice | Q47642850 | ||
| Neuropsychological deficits associated with antiphospholipid antibodies | Q48149596 | ||
| Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes | Q48245672 | ||
| Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer | Q48249236 | ||
| Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings | Q48371040 | ||
| A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? | Q48373517 | ||
| Complex movement disorders in primary antiphospholipid syndrome: a case report | Q48404324 | ||
| Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants | Q48453807 | ||
| Recurrent acute cerebellar ataxia associated with anti-cardiolipin antibodies | Q48476937 | ||
| Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones | Q48556771 | ||
| Neurological antiphospholipid syndrome: Clinical, neuroimaging, and pathological characteristics | Q48573564 | ||
| Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. | Q48629374 | ||
| [Multiple sclerosis and antiphospholipid antibodies: study of 62 consecutive patients]. | Q50860211 | ||
| Diffusion tensor imaging in patients with obstetric antiphospholipid syndrome without neuropsychiatric symptoms. | Q50878689 | ||
| Prothrombotic states in migraine. | Q51025787 | ||
| Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. | Q51056997 | ||
| Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. | Q52008946 | ||
| Neuropsychological functioning and its relationship to antiphospholipid antibodies in patients with systemic lupus erythematosus. | Q52011027 | ||
| Anticardiolipin antibodies in two elderly subpopulations. | Q53212860 | ||
| Anticardiolipin antibodies in Japanese patients with multiple sclerosis. | Q54328083 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 11 | |
| P577 | publication date | 2016-02-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome | |
| P478 | volume | 18 |
| Q92639094 | Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery |
| Q64074958 | Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges |
| Q59808719 | Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy |
| Q91390119 | Antiphospholipid syndrome - an update |
| Q47579053 | Autonomic neuropathy-in its many guises-as the initial manifestation of the antiphospholipid syndrome |
| Q49793897 | Coexistence of antiphospholipid antibodies and cephalalgia. |
| Q47975768 | Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome |
Search more.